ReviewCurrent oncology (Toronto, Ont.)2024

Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer.

Mita Manna et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.